Skip to main content

Table 1 Histopathological diagnosis of 616 adnexal masses

From: Comparison of the diagnostic efficiency between the O-RADS US risk stratification system and doctors’ subjective judgment

Histopathology

N (%)

Benign lesion

469 (76.1)

  Mature cystic teratoma

217 (35.2)

  Ovarian endometriosic cysts

75 (12.2)

  Serous cystadenoma and Mucinous cystadenoma

66 (10.7)

  Adnexal inflammatory mass

44 (7.1)

  Simple cyst

29 (4.7)

  Corpus luteum

6 (1.0)

  Benign mixture ovarian tumor

6 (1.0)

  Other benign tumors

26 (4.2)

Malignant lesion

147 (23.9)

  Adenocarcinoma

57 (9.3)

  Serous cystadenocarcinoma and Mucinous cystadenocarcinoma

25 (4.1)

  Borderline cystadenoma

21 (3.4)

  Granulosa cell tumor

11 (1.8)

  Endometrioid adenocarcinoma

6 (1.0)

  Yolk sac tumor

6 (1.0)

  Immature teratoma and Malignant transformation of mature cystic teratoma

5 (0.8)

  Clear cell tumor

4 (0.6)

  Malignant mixture ovarian tumor

3 (0.5)

  Borderline brenner tumor

1 (0.2)

  Other malignant tumors

8 (1.3)